Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Deep Venous ThrombosisPulmonary Embolism
Interventions
DRUG

LMWH

"Each hospital will use a LMWH according to their own preferences.~Prophylactic dosage of LMWH (for example nadroparin 2850 IE s.c.) once daily for the duration of the immobilization (average 6 weeks). If the patient's weight is more than 100kg a double dose of LMWH will be given (in case of Nadroparin 5700 IE s.c. once daily)."

Trial Locations (8)

8000 GK

De Isala Klinieken, Zwolle

2625 AD

Reinier de Graaf Gasthuis, Delft

2803 HH

Groene Hart Ziekenhuis, Gouda

2333 ZA

Leiden University Medical Center, Leiden

2353 GA

Rijnland Ziekenhuis, Leiderdorp

2512 VA

Medisch Centrum Haaglanden, The Hague

2566 MJ

HagaZiekenhuis, The Hague

2597 AX

Bronovo Ziekenhuis, The Hague

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Suzanne C. Cannegieter, MD PhD

OTHER

NCT01542762 - Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation | Biotech Hunter | Biotech Hunter